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Review Article
Surgical Smoke
Joe King-Man Fan, Fion Siu-Yin Chan and Kent-Man Chu, Department of Surgery, The University of Hong Kong,
Queen Mary Hospital, Hong Kong SAR.
Surgical smoke is the gaseous by-product formed during surgical procedures. Most surgeons, operating
theatre staff and administrators are unaware of its potential health risks. Surgical smoke is produced by
various surgical instruments including those used in electrocautery, lasers, ultrasonic scalpels, high speed
drills, burrs and saws. The potential risks include carbon monoxide toxicity to the patient undergoing a
laparoscopic operation, pulmonary fibrosis induced by non-viable particles, and transmission of infec-
tious diseases like human papilloma virus. Cytotoxicity and mutagenicity are other concerns. Minimisa-
tion of the production of surgical smoke and modification of any evacuation systems are possible solutions.
In general, a surgical mask can provide more than 90% protection to exposure to surgical smoke; how-
ever, in most circumstances it cannot provide air-tight protection to the user. An at least N95 grade or
equivalent respirator offers the best protection against surgical smoke, but whether such protection is
necessary is currently unknown. [Asian J Surg 2009;32(4):253–7]
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Introduction
“Surgical smoke” is the gaseous by-product produced
during surgical procedures. It is also known as aerosols,
cautery smoke, diathermy plume, plume or smoke plume.
Most surgeons, operating theatre staff, and administra-
tors are unaware of its health risks. A recent survey in the
UK revealed that only 3 of 98 surgeons used dedicated
smoke extractors, although 72% of surgeons felt that
inadequate precautions were taken to protect staff and
patients from surgical smoke.1
In general, surgical smoke is produced by electro-
cautery devices, laser ablation, ultrasonic scalpels, high
speed drills, burrs and saws as a result of disruption and
vaporisation of tissue protein and fat.2 It hinders the vision
of the surgeon, produces an unpleasant odour, and releases
harmful substances into the air.3 Studies have shown that
these substances could cause headaches, irritation of the
eyes and other mucous membranes, and could also result
in other potential long-term effects.4,5 Epidemiological
and toxicological studies have also shown that exposure
to particulate air pollution is associated with adverse
effects on the cardiovascular and respiratory systems as
well as with increased mortality.6–8
This article reviews the potential hazards of surgical
smoke and provides recommendations to the surgical
community based on current knowledge available in the
literature.
Potential Hazards
Carbon monoxide production
The production of carbon monoxide (CO) during tissue
ablation is most commonly seen during diathermy appli-
cation.9 This may be a result of either incomplete combus-
tion or the presence of carbon dioxide during laparoscopic
procedures. The production of CO is enhanced by the pres-
ence of high carbon dioxide levels in the peritoneal cavity
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and increased intra-abdominal pressure during laparo-
scopic surgery. Carbon monoxide, which acts as a com-
petitor to the oxygen molecule for haemoglobin, causes
tissue hypoxia. The CO level in the patient’s blood is sig-
nificantly increased after a laparoscopic cholecystectomy,
even in healthy non-smokers. Preventive measures include
hyperventilation with a high concentration of oxygen 
(e.g. 50–100%), and aggressive evacuation of the surgical
smoke.10
Non-viable particles
Particles of various sizes are produced by surgical instru-
ments (Table 1). The smaller the particles, the further the
distance they can travel in air. Smaller particles could
therefore affect the non-scrubbed staff in the operating
theatre. Particles that range in size from 0.5 to 5.0 μm are
considered to be “lung damaging dust”. They carry the risk
of bronchiolitis, emphysema and pulmonary fibrosis.
These pathological changes have been shown in a rat
model.11,12
It has been shown recently that electrocautery and
argon plasma coagulation induced the production of 
a very high number concentration (> 100,000 cm−3) of
particles with diameters ranging from 10 nm to 1 μm.13
The peak concentration was confined to the immediate
local surrounding of the surgical site.13
Viable bacteria and viruses
Of the bacterial cultures grown on specimens collected
from laser plume smoke during laser procedures in 13
patients, five grew coagulase-negative Staphylococcus.14 Of
these five positive cultures, one also grew Corynebacterium
and the other grew Neisseria.14
There is substantial evidence showing the presence of
viable viruses in surgical smoke. A surgeon was reported to
have developed laryngeal papillomatosis after neodymium:
yttrium-aluminium-garnet laser treatment for a patient
with anogenital condylomata due to human papillo-
mavirus (HPV) infection. In situ DNA hybridisation of
the laryngeal papilloma tissues showed that the HPV 
was of types 6 and 11, same as that of the patient.15
In another study, intact viral DNA could be demonstrated
in the plume collected during carbon laser therapy of
papillomavirus-infected verrucae.16 The same investiga-
tors subsequently confirmed the infectivity of the laser
plume by inoculation into the skin of calves.17 These find-
ings support the possibility of viral transmission through
surgical smoke.
Viable human immunodeficiency virus (HIV) was
demonstrated in cool aerosols generated by devices 
like Midas Rex (Medtronic Inc, Minneapolis, MN, USA)
and Stryker (Stryker Instruments, Kalamazoo, MI, USA)
oscillating bone saws but not in fumes generated by elec-
trocautery.18 HIV DNA has also been found in surgical
smoke and it remained viable for 14 days. However, its
infectivity to humans is uncertain and further studies are
needed.19
Studies have shown that smoke generated by ultra-
sonic scalpels has a lower temperature and is more likely
to contain more infectious material than smoke of higher
temperatures.18
Viable cells
Intact cells and blood components are aerosolised by
laser, electrocautery, and ultrasonic scalpels. Potential
risks include the spread of infection to health care workers,
and dissemination of cancer cells. Viable melanoma cells
were demonstrated by trypan blue assay and tetrazolium
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide] (MTT) in a plume generated by electrocautery
of mouse melanoma cells.20 This may account for the
well-known phenomenon of tumour recurrence in a port
site remote from where a tumour was previously extracted
after laparoscopic resection.21 One of the proposed mech-
anisms is the “chimney effect”—the leakage of gas carry-
ing viable cells through port sites during laparoscopic
surgery.22 It is interesting to note that ultrasonic scalpels
did not produce viable cancer cells during dissection.23
Chemicals and cytotoxicity
Various chemical compounds (Table 2) have been isolated
in surgical smoke—for example, hydrogen cyanide, ben-
zene, hydrocarbons, nitriles, fatty acids, and phenols.2,24–26
These compounds were responsible for the noxious odour
of surgical smoke. Acrylonitrile is a colourless volatile 
liquid that will liberate cyanide and is easily absorbed
Table 1. Sizes of particles produced by different surgical instruments
Instrument Size (μm)
Electrocautery 0.007–0.42
Laser 0.1–0.8
Ultrasonic scalpel 0.35–6.5
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through the skin and lungs. Acrylonitrile liberates hydro-
gen cyanide. Cyanide may exert its harmful effect by inhibit-
ing intra-cellular oxygen utilisation through blocking
cytochrome oxidase activity.
Potential mutagenicity of surgical smoke has been
studied using Salmonella typhimurium with the standard
Salmonella microsomal test (Ames test). Mutation of the
bacteria was found after exposure to smoke created by 
electrocautery or laser ablation.27,28 A dose-response 
relationship was also observed. Similarly, a dose-dependent
reduction in clonogenicity of MCF-7 human breast cancer
cells was observed when these cells were exposed to surgi-
cal smoke.29
Sugimura et al and Commoner et al first called atten-
tion to the mutagenicity of smoke from cooking food,
especially meat.30–32 More than ten kinds of mutagenic
heterocyclic amines (HCAs) are produced by cooking or
heating of meat or fish.30 When HCAs were fed to experi-
mental animals on a long-term basis, they developed 
cancers in many organs, including the colon, breast, and
prostate.30 The carcinogenic potential of these compounds
is therefore well established. Whether long-term inhala-
tion of smoke containing HCAs or surgical smoke will
induce cancer development in humans is not yet certain.
A recent study showed that lung cancer risk was not
increased in operating room nurses.33
One of the major groups of chemical compounds pro-
duced by electrocautery is hydrocarbons (Table 2). It has
been shown by Rivedal et al that 12 of the 13 hydrocar-
bons tested either induced morphological transformation
or inhibited intercellular communication in Syrian ham-
ster embryo cells.34,35
After subjecting the aerosols produced by laser irradi-
ation of porcine tissues to several laboratory tests, Plappert
et al concluded that the particulate fraction of aerosols
have to be classified as cytotoxic, genotoxic, clastogenic,
and mutagenic.36
Recommendations
To ensure safety of medical staff and patients, the 
best approach is to minimise the production of surgical
smoke, increase the efficacy of the evacuation of smoke,
and prevent inhalation of smoke by use of effective
masks.
Minimise the production of surgical smoke
Unnecessary ablation of tissue should be avoided. Apart
from production of surgical smoke, unnecessary ablation
also increases the amount of dead tissue and risk of infec-
tion. Additionally, the production of smoke during laparo-
scopic surgery obscures the surgical vision field of surgeons
and hence poses a potential risk to the patient.3
Increase the efficacy of smoke evacuation
A suction device should be considered, especially during
laparoscopic surgery, to evacuate the smoke produced. 
A proper filter should also be used in the exhaust port of
the collection device; otherwise the constituents of the
smoke can escape into the operating room. Moreover, a
Table 2. Examples of chemical compounds found in surgical
smoke
Hydrocarbons
● Acetylene
● Benzene
● 1-Decene 
● 2,3-dihydro indene
● Ethyl benzene
● Ethynyl benzene
● Styrene
● Toluene
● 1-Undecene
Nitriles
● Acetonitrile
● Acrylonitrile
● Benzonitrile 
● 3-Butenenitrile
● 2-Prophylene nitrile
Amines
● Indole
● 6-Methyl indole
● Pyrrole
Aldehydes
● Acrylaldehyde
● Benzaldehyde 
● Formaldehyde
● Furfural
● 3-Methyl butenal
● 2-Methyl propanol
Miscellaneous
● Hexadecanoic acid
● 2-Methyl furan2,5-dimethyl furan
● 4-Methyl phenol
● Methyl pyrazine
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valve or filter may be used in the laparoscopic port to
avoid leakage of smoke.
The National Institute for Occupational Safety 
and Health (NIOSH) of the United States recommended
the combination of general room and local exhaust 
ventilation to remove the airborne contaminants gener-
ated by surgical devices.37 A suction device with a capture
velocity of 100–150 feet per minute is recommended. 
A high efficiency particulate air (HEPA) or equivalent fil-
ter should be used at the same time. Staff should ensure
proper maintenance of these devices and filters. The 
suction nozzle should be kept within 2 inches of the 
surgical site to ensure effective capture of airborne 
contaminants.
Prevention of inhalation by effective masks
Effective masks/respirators can protect health care work-
ers from inhaling surgical smoke. Proper use of the mask
is also important.
The most commonly used mask is a simple surgical
face mask, which usually has three layers. Such masks are
able to achieve 95–99% bacterial filtration efficiency (BFE)
and 91–95% particulate filtration efficiency (PFE). BFE is
a measure obtained by challenging a mask with bacteria
contained in droplets that are 4 μm or larger. The most
common method used nowadays is to generate aerosols
by a nebulizer loaded with Staphylococcus aureus in 0.1%
peptone solution. Microbiological culture and counting
is then performed after 24 hours of inoculation. PFE is
measured by challenging a mask with 0.1–0.3 μm aerosols.
The main drawback of surgical masks (either ear-loop or
tie) is that it cannot provide a snug fit so smoke or its con-
stituents can still be inspired via the loose points. The
other alternative is a respirator.
Health Care Particulate Respirators can be categorized
into N, R and P classes.38 In short, N stands for not resis-
tant to oil, R for resistant to oil, and P for oil proof. N class
respirators are designed to filter out particles that are
non-oil based. N95 can achieve > 95% filter efficiency
when tested with ∼0.3 μm sodium chloride aerosol. The R
and P types of respirators are intended for filtering any
particles with oil-based liquid aerosols. Grade 100 respi-
rators can achieve > 99.97% filter efficiency when chal-
lenged with ∼0.3 μm aerosols. Although NIOSH has not
provided any guidelines on the use of respirators for surgi-
cal procedures, it seems that respirators that are at least
N95 grade provide the best protection against surgical
smoke produced during the use of electrocautery, lasers,
or ultrasonic scalpels.
Current status
Various professional organisations, including the American
National Standards Institute (ANSI), the Association 
of Operating Room Nurses (AORN), and the American
Society for Laser Medicine and Surgery, have issued 
position statements recommending the use of local
exhaust ventilation during procedures in which surgical
smoke is produced.39
Nevertheless, a recent web-based survey of AORN
members from various medical specialties and facilities
throughout North America indicated that many facilities
have not implemented best practices for protecting
patients and health care workers from the hazards of sur-
gical smoke.39
Conclusion
Surgeons and operating theatre staff should be made
aware of the potential risks of surgical smoke. While some
immediate untoward effects like odour and irritation of
mucous membranes may appear minor, the potential
long-term health hazards as discussed in this article
should not be ignored. We should take appropriate mea-
sures to protect ourselves and our patients, as potential
effects may only develop decades later.
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